换一批
换一批Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors.
第一作者：
Sara,Charmsaz
第一单位：
Leukaemia Foundation Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia; Department of Medicine, University of Queensland, Brisbane, Australia; Department of Surgery, Royal College of Surgeons, Dublin, Ireland. Electronic address: saracharmsaz@rcsi.ie.
作者：
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗体依赖细胞细胞毒性(Antibody-Dependent Cell Cytotoxicity);抗肿瘤药(Antineoplastic Agents);补体激活(Complement Activation);细胞毒素类(Cytotoxins);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);血液肿瘤(Hematologic Neoplasms);人类(Humans);免疫轭合物(Immunoconjugates);免疫调节(Immunomodulation);免疫疗法(Immunotherapy);分子靶向治疗(Molecular Targeted Therapy);肿瘤蛋白质类(Neoplasm Proteins);受体, Eph家族(Receptors, Eph Family)
DOI
10.1016/j.exphem.2017.07.003
PMID
28751189
发布时间
2018-02-24
- 浏览4
Experimental hematology
31-39页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
